#260of 1,000 in 2025

Reboot Rx Inc

Location
Winchester, Massachusetts
Sector
Medical research
Founded
2020
Website
rebootrx.org
614%Three-year growth, FY2022 to FY2025
$2.1MFY2025 revenue
18Employees, FY2025
#3of 6 in Medical research
#6of 34 in Massachusetts

Revenue by fiscal year

FY2022: $294,350 $294K FY22 FY2023: $495,172 $495K FY23 FY2024: $1,514,536 $1.5M FY24 FY2025: $2,102,479 $2.1M FY25

We count pledges when the cash is received, not when they’re promised, so these numbers differ from Reboot Rx Inc’s 990. How we count pledges

Where revenue came from, FY2025

Gifts and grants
$2.1M · 100%
Total revenue on the 990
$1,047,549
Investment income
− $97,849
Pledge payments received this year, promised in an earlier year
+ $1,152,779
Revenue we count
$2,102,479

What it does

Reboot Rx is a nonprofit that expands access to affordable cancer treatments by repurposing generic drugs.

Reboot Rxs work focuses on: 1) aggregating public clinical evidence to surface existing medicines with strong data and potential impact in cancer care; 2) evaluating the evidence, and, where appropriate, supporting generating additional evidence through research partnerships; and 3) sharing clear, synthesized findings with clinicians, researchers, and health systems to support patient care.

Leadership

Laura KleimanPresident CEO and Director
Sherif BotrosVP of Data Science

EIN 84-4384737 · Full filings on ProPublica

Want to share your story?

We’d love to hear your story of growth.

Share your story